Search research articles
Contact Us
Filters
Showing results (211-220 of 397) with videos related to
Page
of 40
Sort By:
Advanced Materials (Deerfield Beach, Fla.)
|
July 7, 2011
Effect of acene length on electronic properties in 5-, 6-, and 7-ringed heteroacenes
Katelyn P Goetz, Zhong Li, Jeremy W Ward, et al.
Plos One
|
May 13, 2014
Aurora-A mitotic kinase induces endocrine resistance through down-regulation of ERα expression in initially ERα+ breast cancer cells
Mateusz Opyrchal, Jeffrey L Salisbury, Shuya Zhang, et al.
Biorxiv : the Preprint Server for Biology
|
April 8, 2024
OmicsFootPrint: a framework to integrate and interpret multi-omics data using circular images and deep neural networks
Xiaojia Tang, Naresh Prodduturi, Kevin J Thompson, et al.
Breast Cancer Research and Treatment
|
July 4, 2021
A clinical calculator to predict disease outcomes in women with hormone receptor-positive advanced breast cancer treated with first-line endocrine therapy
Mei-Yin C Polley, Maura N Dickler, Jason Sinnwell, et al.
Nucleic Acids Research
|
October 24, 2024
OmicsFootPrint: a framework to integrate and interpret multi-omics data using circular images and deep neural networks
Xiaojia Tang, Naresh Prodduturi, Kevin J Thompson, et al.
Plos One
|
February 6, 2013
Endoxifen's molecular mechanisms of action are concentration dependent and different than that of other anti-estrogens
John R Hawse, Malayannan Subramaniam, Muzaffer Cicek, et al.
Endocrinology
|
October 5, 2017
Skeletal and Uterotrophic Effects of Endoxifen in Female Rats
Anne Gingery, Urszula T Iwaniec, Malayannan Subramaniam, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 10, 2003
Phase I and pharmacokinetic study of two different schedules of oxaliplatin, irinotecan, Fluorouracil, and leucovorin in patients with solid tumors
Matthew P Goetz, Charles Erlichman, Anthony J Windebank, et al.
Cancers
|
September 9, 2022
Identification of Src Family Kinases as Potential Therapeutic Targets for Chemotherapy-Resistant Triple Negative Breast Cancer
Ishwar N Kohale, Jia Yu, Yongxian Zhuang, et al.
Journal of Clinical Pharmacology
|
March 31, 2022
Population Pharmacokinetics of Z-Endoxifen in Patients With Advanced Solid Tumors
Emily J Koubek, Andrew T Ralya, Thomas R Larson, et al.
Page
of 40
Search research articles
Search
Showing results (211-220 of 397) with videos related to
Sort By:
Page
of 40
Advanced Materials (Deerfield Beach, Fla.)
|
July 7, 2011
Effect of acene length on electronic properties in 5-, 6-, and 7-ringed heteroacenes
Katelyn P Goetz, Zhong Li, Jeremy W Ward, et al.
Plos One
|
May 13, 2014
Aurora-A mitotic kinase induces endocrine resistance through down-regulation of ERα expression in initially ERα+ breast cancer cells
Mateusz Opyrchal, Jeffrey L Salisbury, Shuya Zhang, et al.
Biorxiv : the Preprint Server for Biology
|
April 8, 2024
OmicsFootPrint: a framework to integrate and interpret multi-omics data using circular images and deep neural networks
Xiaojia Tang, Naresh Prodduturi, Kevin J Thompson, et al.
Breast Cancer Research and Treatment
|
July 4, 2021
A clinical calculator to predict disease outcomes in women with hormone receptor-positive advanced breast cancer treated with first-line endocrine therapy
Mei-Yin C Polley, Maura N Dickler, Jason Sinnwell, et al.
Nucleic Acids Research
|
October 24, 2024
OmicsFootPrint: a framework to integrate and interpret multi-omics data using circular images and deep neural networks
Xiaojia Tang, Naresh Prodduturi, Kevin J Thompson, et al.
Plos One
|
February 6, 2013
Endoxifen's molecular mechanisms of action are concentration dependent and different than that of other anti-estrogens
John R Hawse, Malayannan Subramaniam, Muzaffer Cicek, et al.
Endocrinology
|
October 5, 2017
Skeletal and Uterotrophic Effects of Endoxifen in Female Rats
Anne Gingery, Urszula T Iwaniec, Malayannan Subramaniam, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 10, 2003
Phase I and pharmacokinetic study of two different schedules of oxaliplatin, irinotecan, Fluorouracil, and leucovorin in patients with solid tumors
Matthew P Goetz, Charles Erlichman, Anthony J Windebank, et al.
Cancers
|
September 9, 2022
Identification of Src Family Kinases as Potential Therapeutic Targets for Chemotherapy-Resistant Triple Negative Breast Cancer
Ishwar N Kohale, Jia Yu, Yongxian Zhuang, et al.
Journal of Clinical Pharmacology
|
March 31, 2022
Population Pharmacokinetics of Z-Endoxifen in Patients With Advanced Solid Tumors
Emily J Koubek, Andrew T Ralya, Thomas R Larson, et al.
Page
of 40